Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Danish Center to Use Elekta AB's Clarity Soft Tissue Imaging to Guide Radiotherapy for Cancer Patients


Friday, 12 Oct 2012 09:00am EDT 

Elekta AB announced that Copenhagen University Hospital (CUH, Herlev) is the first hospital in Scandinavia to acquire the Company's Clarity soft tissue visualization system with Autoscan. CUH medical physicist Mariwan Baker, will use Clarity to further quantify the value of non-invasive, non-ionizing 3D ultrasound in increasing radiation therapy precision. The first projects will involve Clarity studies of gynecological and prostate targets. Mr. Baker's research focuses on the potential to use Clarity for addressing the magnitude of uterus displacement in gynecological patients on a daily basis. Furthermore, the research encompasses the implementation of Clarity for 4D monitoring - to evaluate intrafraction changes in prostate position. Mr. Baker will first assess the extent of prostate shifts and build on that knowledge by examining dosimetry variations caused by intrafraction prostate motion. To accomplish this, Mr. Baker will be using Clarity 3D with Autoscan along with a 4D phantom that will be developed by CUH for ultrasound tracking with embedded real-time detectors. In addition to prostate and gynecological Clarity research, Mr. Baker mentioned the potential of an initial study on imaging the tumor cavity movement in post-operative breast cancer patients. Mr. Baker predicts that clinical use of Clarity at CUH will begin in early 2013. 

Company Quote

84.0
0.15 +0.18%
23 Jul 2014